<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(6)</volume><submitter>Kalender Atak Z</submitter><pubmed_abstract>With the advent of whole-genome and whole-exome sequencing, high-quality catalogs of recurrently mutated cancer genes are becoming available for many cancer types. Increasing access to sequencing technology, including bench-top sequencers, provide the opportunity to re-sequence a limited set of cancer genes across a patient cohort with limited processing time. Here, we re-sequenced a set of cancer genes in T-cell acute lymphoblastic leukemia (T-ALL) using Nimblegen sequence capture coupled with Roche/454 technology. First, we investigated how a maximal sensitivity and specificity of mutation detection can be achieved through a benchmark study. We tested nine combinations of different mapping and variant-calling methods, varied the variant calling parameters, and compared the predicted muta</pubmed_abstract><journal>PloS one</journal><pagination>e38463</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3366948</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>High accuracy mutation detection in leukemia on a selected panel of cancer genes.</pubmed_title><pmcid>PMC3366948</pmcid><pubmed_authors>Porcu M</pubmed_authors><pubmed_authors>Quentmeier H</pubmed_authors><pubmed_authors>Dirks WG</pubmed_authors><pubmed_authors>Kalender Atak Z</pubmed_authors><pubmed_authors>Cloos J</pubmed_authors><pubmed_authors>Aerts S</pubmed_authors><pubmed_authors>Cuppens H</pubmed_authors><pubmed_authors>Cools J</pubmed_authors><pubmed_authors>Vandenberghe P</pubmed_authors><pubmed_authors>Uyttebroeck A</pubmed_authors><pubmed_authors>Geerdens E</pubmed_authors><pubmed_authors>Lahortiga I</pubmed_authors><pubmed_authors>Vandepoel R</pubmed_authors><pubmed_authors>De Keersmaecker K</pubmed_authors><pubmed_authors>Gianfelici V</pubmed_authors><pubmed_authors>Pauwels D</pubmed_authors><pubmed_authors>Brys V</pubmed_authors></additional><is_claimable>false</is_claimable><name>High accuracy mutation detection in leukemia on a selected panel of cancer genes.</name><description>With the advent of whole-genome and whole-exome sequencing, high-quality catalogs of recurrently mutated cancer genes are becoming available for many cancer types. Increasing access to sequencing technology, including bench-top sequencers, provide the opportunity to re-sequence a limited set of cancer genes across a patient cohort with limited processing time. Here, we re-sequenced a set of cancer genes in T-cell acute lymphoblastic leukemia (T-ALL) using Nimblegen sequence capture coupled with Roche/454 technology. First, we investigated how a maximal sensitivity and specificity of mutation detection can be achieved through a benchmark study. We tested nine combinations of different mapping and variant-calling methods, varied the variant calling parameters, and compared the predicted muta</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012</publication><modification>2026-04-30T17:58:46.83Z</modification><creation>2026-04-07T16:15:08.623Z</creation></dates><accession>S-EPMC3366948</accession><cross_references><pubmed>22675565</pubmed><doi>10.1371/journal.pone.0038463</doi></cross_references></HashMap>